Thomas D.

Thomas D. has a strong background in finance and analytics, with experience spanning multiple industries. Thomas currently holds the position of Director, Analytics & Forecasting, Commercial Effectiveness at Insmed Incorporated. Prior to this, they worked at The Janssen Pharmaceutical Companies of Johnson & Johnson, where they served as the Global Commercial Insights Lead for New Business Development & Analytics and the Global Commercial Analytics & Forecasting Lead for Pulmonary Hypertension. Before joining Janssen, Thomas worked as the Finance Director for Oncoloy, Hematology & PAH at Janssen Europe, Middle East & Africa (EMEA). Thomas also held the role of Finance Director for Regional Commercial Operations EMEA & LATAM at Actelion, which was acquired by Janssen in 2017. Thomas began their career at Umicore, where they served as the Business Unit Controller for Thin Film Products and later as the Internal Audit Manager. Thomas also worked as the Director of Internal Audit at Dover Corporation.

Thomas D. has a comprehensive education history. Thomas completed a Corporate Finance Programme at the London Business School from 2013 to 2017. Prior to this, they pursued an Executive Master Class in Corporate Finance at Vlerick Business School from 2010 to 2011. Thomas D. also obtained an Executive Master in General Management (CEPAC) from the Solvay Brussels School of Economics and Management between 2005 and 2007. Furthermore, they hold a Master's degree in Sc. Management from the Louvain School of Management, which they received from 1992 to 1997. In 1996, Thomas D. participated in an Intl Exchange Program in International Finance at the UBC Sauder School of Business.